Respirology

Article	Citations
	167
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	91
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	69
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	68
Issue Information	56
Broadening Our Understanding of Genetic Risk to Interstitial Lung Disease in Understudied Populations	55
World Lung Day 2025—Healthy Lungs, Healthy Life	55
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2	52
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	46
Omics technologies to study virus infection and chronic lung diseases	45
Language concordance in healthcare: Beyond just talk	45
APSR 2024 Abstracts	43
The Brompton Breathing Pattern Assessment Tool ( BPAT ): A Journey to Identify the Unknown, a Decade on…	41
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	41
Effectiveness of Active Video Games as a Training Tool in Patients With Interstitial Lung Disease: A Randomised Controlled Trial	39
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	39
Bayesian adaptive clinical trial designs for respiratory medicine	36
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	36
Issue Information	34
Prenatal PM 2 .5 Exposure and Airway Mech	34
Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbation	34
	33
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	32
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	32
The chicken or the egg: Sleep or physical activity?	32

Adding some NOVELTY to treatable traits	30
Singing in and out of COVID	30
Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High‐Risk Individuals	30
Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Pr	30
A New Opportunity in Respirology	28
Issue Information	27
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	26
Letter From The Philippines—Breathing Life Into the Nation: The Philippine College of Chest Physicians and Its Impact on Respiratory Health	26
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	25
Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14 ‐ and <	25
Obesity is a major contributing cause of breathlessness in the population	24
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	24
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	24
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis	23
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	23
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	23
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	23
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	23
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	22
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	21
Abstract	21
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	21
	21
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	20
My Lungs Have Feelings Too!	20
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	20
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	20
Issue Information	20
Issue Information	19
Issue Information	18
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD	18
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	18
Conspiracy Theories, MDTs and Communication	18
	18
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	17
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	17
Severe asthma, more than that?	16
The 63rd Annual Meeting of the Japanese Respiratory Society	16
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	16
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	16
Sleep medicine is more than just obstructive sleep apnoea	16
Letter from Vietnam	15
Corrigendum	15
Erythromycin Shortage in an NTM ‐Endemic Country: Implications for Bronchiectasis Care and Antimicrobial Stewardship	15
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	15
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	15
A Comprehensive Review of Interstitial Lung Abnormalities	15
Issue Information	14
Letter from the United States: An update on the New York experience with COVID‐19	14
Leading Women in Respiratory Clinical Sciences: Letter From Japan	14

Author Index	14
Transformative radiology: Chest imaging is being re‐defined	14
	14
	14
Hansen's disease and the first patient disease Registry	14
	13
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	13
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	13
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	13
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	13
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	13
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	13
	13
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	12
Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort St	12
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	12
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	12
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	12
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	11
Issue Information	11
Issue Information	11
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	11
	11
Correction to “ APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	10
Letter from Iceland	10
Contemporary Concise Review 2023: Interstitial lung disease	10
Tackling a Lifetime of Risk for OSA	10
	10
Patients' and Health Professionals' Views on Using Oral Corticosteroids for Asthma: Priorities, Trade‐Offs and Shared Decision‐Making	10
Illness, chocolate and Harry Potter	10
Ηeparan sulphate in infectious and non‐infectious exacerbations of COPD	10
Adaptation in real time: Wildfire smoke exposure and respiratory health	10
A visit to the gallery	10
Breath‐holding physiology, radiological severity and adverse outcomes in COVID‐19 patients: A prospective validation study	10
Current evidence on supranormal lung function: A call for longitudinal research to optimize lung health	10
Robotic One Anaesthetic Marking And Resection ( ROMAR ): A Novel Approach for Thoracoscopic Sublobar Resection of Peripheral Pulmonary Lesions	10
A Mechanistic and Morphologic Approach to Managing Benign Central Airway Obstruction	9
Letter From the Sri Lanka College of Pulmonologists	9
Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	9
Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial ( BRON	9
A Novel Method Using Dual‐Energy Computed Tomography for Detecting Amiodarone‐Induced Lung Injury: A Cohort Pilot Study	9
The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes	9
Early Intervention With Biologics for Asthma Remission: Promising or Premature?	9
Small Airways and Pulmonary Diffusing Capacity Decline in an 8‐Year Longitudinal Population Study	9
Issue Information	9
Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2‐agonists	9
Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio‐sampling of the lower airways in children and adults	8
Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap	8
Letter from the Czech Republic	8
Reply to: ‘Is continuous positive airway pressure truly superior to high‐flow nasal cannula in managing acute hypoxemic respiratory failure?’	8
The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May Be Underestimated	8
COPD‐related incidence, mortality, and disability: An illustrative summary of the GBD study (1990–2019)	8
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension	8
Smoking: Quit to win	8
Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis	8
Consumer engagement—Beyond the usual approaches	8
NT ‐ proBNP and BNP Testing in Pulmonary Arterial Hypertension: Poi	8
Plastics in Every Breath: The Silent Respiratory Health Threat We Cannot Avoid	8
Recommendations from The Medical Education Editor	8
Looking Towards More Comprehensive Management of Interstitial Lung Disease	8
Cough suppression as a radical but effective therapeutic strategy	8
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (	8
Siloed thinking is limiting health care delivery	8
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules	8
Extracellular traps are evident in Romanowsky‐stained smears of bronchoalveolar lavage from children with non‐cystic fibrosis bronchiectasis	8
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases	8
Contemporary Concise Review 2023: Environmental and occupational lung diseases	7
Inflammation‐induced loss of CFTR ‐expressing airway ionocytes in non‐eosinophilic asthma	7
Small babies at birth, small lungs for life?	7
Home sweet home… or is it?	7
Urban living	7
	7
World Lung Day 2023—Access to prevention and treatment for all, leave no one behind	7
Stirring the publishing pot by ending accept/reject decisions	7
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction	7
The treatable traits approach to adults with obstructive airways disease in primary and secondary care	7
The SINFONIA Study: A Randomised Controlled Trial to Determine Feasibility and Effectiveness of Online Group Singing for People With	7
Understanding Nontuberculous Mycobacterial Pulmonary Disease as a Chronic Lung Disease	7
The Case for Case Finding Is Getting Stronger	7
Into the meaning of Respirology, Pulmonology and Pneumology	6

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial	6
Preliminary Development of a Patient‐Reported Outcome Measure for Inducible Laryngeal Obstruction: Findings From a Delphi Process	6
Letter from the UK: Reflections on a turbulent 5 years	6
Issue Information	6
A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy	6
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial	6
Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients	6
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study	6
	6
Reliability of Rapid On‐Site Evaluation Achieved by Remote Sharing Systems (E‐ ROSE ) and AI Algor	6
Letter from South Africa	6
Letter from Belgium	6
What Matters for Prediction? Leukocyte Count and Risk Stratification in Pulmonary Embolism	6
Issue Information	6
Pre‐transplant anti‐fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti‐fibrotics?	6
High‐Flow Nasal Oxygen in Early Home Pulmonary Rehabilitation for Exertional Hypoxaemia: A Pilot Randomised Feasibility Trial	6
Issue Information	6
Pathological Examination and Genetic Mutation Testing: Bridging Their Best Practices Using MINtS	6
Leading women in respiratory clinical sciences: Letter from Australia	6
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?	6
Breaking the spiral: How negative mood can fuel exertional breathlessness in people with chronic obstructive pulmonary disease	6
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	6
Letter From the Vietnam Respiratory Society—Vietnam's Respiratory Medicine in Transition: From Clinical Advances to National Healthcare Policy	6
Clinical and Inflammatory Phenotypes During Exacerbations Predict In‐Hospital Adverse Outcomes in Asthma‐ COPD Overlap	6
Checkpoint inhibitors are a basic science‐based, transformative new treatment for lung cancer	6
Long‐term trends of COPD mortality: Gaps and opportunities	6
	6
Cardiovascular Effect of Snoring in Asians: What Do Biobank and Genomic Studies Say?	6
Covid‐19 pandemic and asthma: What did we learn?	5
Overexpression of SMAD7 improves the function of EGFR‐targeted human CAR‐T cells against non‐small‐cell lung cancer	5
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled tr	5
	5
A paediatric bronchoscopist's ‘Field of Dreams’: Will the flexible cryoprobe hit a home run?	5
TSANZ Abstracts	5
Author Index	5
Prenatal Air Pollution Exposure and Child Lungs: Innovations in Measurement and Causal Inference	5
Clinical trials and clinical trials networks	5
Contemporary Concise Review 2024: Respiratory Infections	5
Correction to “Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions”	5
Update on the Pathophysiology, Aetiology and Management of Central Sleep Apnoea	5
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement	5
Leading women in Respiratory Medicine: Letter from the ERS	5
Quantum Respiratory Science	5
Risk of childhood asthma in those born small	5
Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Targe	5
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease	5
Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study	5
Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre‐	5
Effects of early mobilization on patients with COVID‐19 with respiratory failure	5
From Residency to Tissue Inflammatory Memory: HLF as a Transcriptional Gatekeeper of CD4 +	5
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning	5
	5
Safety of Pulmonary Rehabilitation in Acute Exacerbations of Interstitial Lung Disease: A Multicentre Study	5
How does one get around many of the confounding factors influencing the response to methacholine?	4
Bronchiectasis: A pulmonary disease with systemic consequences	4
Issue Information	4
Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics	4
Issue Information	4
Aetiology of Adult Community‐Acquired Lung Abscess in Hong Kong	4
Silicosis—Where to from here?	4
Auto‐adjusted versus fixed positive airway pressure in patients with severe OSA: A large randomized controlled trial	4
Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET	4
Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth	4
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	4
Issue Information	4
PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis	4
Heated Tobacco Product Use and Lower Physical Activity Among Japanese Adults With and Without Respiratory Diseases: Findings From the JACSIS Study	4
Lifetime Body Mass Index Trajectories and Contrasting Lung Function Abnormalities in Mid‐Adulthood: Data From the Tasmanian Longitudinal Health Study	4
Rheumatoid factor and anti‐citrullinated antibodies in non‐connective tissue interstitial lung disease: The chicken or the egg?	4
Local knowledge: Every surfer knows the feeling	4
The commercial determinants of respiratory health	4
GLP ‐1‐Based Therapy for Obstructive Sleep Apnoea	4
Reply to “Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification”	4
Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population	4
CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life	4
Recommendations From the Medical Education Editor	4
Food for the Lungs: The Mediterranean Diet and Adult‐Onset Asthma	4
Sputum Metagenomics Reveals Multidrug‐Resistant Pseudomonas‐Dominant Communities in Severe Asthma	4
Fixed Pressure Wins Again: Why Obesity Hypoventilation Syndrome Demands Stability	4
PDE5 to keep them alive: The use of phosphodiesterase type‐5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease	4
Which biologic? New findings from a real‐world study	4
Small for gestational age is associated with reduced lung function in middle age: A prospective study from first to fifth decade of life	4
Issue Information	4
Response to ‘Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients’	4
Obstructive Sleep Apnoea Treatments—Where Are We Now?	4
Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification	4
Inter‐Night Variability of Nocturnal Pulse Oximetry in People Living With Motor Neuron Disease: A Retrospective Observational Study	4
Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics	4
Issue Information	4
Evaluating artificial intelligence responses to respiratory medicine questions	4
Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients	4
Non‐Intubated VATS for Interstitial Lung Disease Diagnosis: A Safer Technique or Too Soon to Tell?	4